Navigation Links
The Efficacy Of Newer Stents Questioned

People who undergo a balloon angioplasty to open a clogged artery often receive a stent as well a small, wire-mesh device inserted into the artery// to keep it from closing. The problem with older stents, however, has been that they can trigger an immune response from the cells in the walls of the artery that cause the artery to become occluded.

Stents coated with drugs to stop this process have been touted as the answer to this problem. Researchers after having collected data from 11 studies comparing bare-metal stents with the newer drug-eluting stents say that their results show people who had the drug-eluting stents were significantly less likely than those receiving the bare-metal stents to experience severe cardiac events, 8 percent vs. 16 percent. They were also more likely to avoid an episode of restenosis, or reblocking of the artery, six to 12 months later, a common problem for anyone undergoing balloon angioplasty. Thirty percent of the bare-metal stent patients experienced reblockage compared to just 9 percent of those who got a drug-eluting stent.

The analysis found no difference in mortality rates or subsequent heart attacks in the two groups. However researchers say long term follow-up is needed to fully determine the safety and effectiveness of drug-eluting stents, especially in patients considered at high risk of complications.
'"/>




Page: 1

Related medicine news :

1. Efficacy Of Meningitis C Vaccine
2. The Efficacy Of Allergy Shots Questioned
3. The Efficacy Of Hormone Replacement Therapy Studied
4. Ambiguous Efficacy Of Opioid Drugs In Chronic Inflammatory Joint Pain Relief
5. Efficacy of fish oil supplements in pregnancy.
6. Efficacy of Omega 3 Fatty Acids Needs Wider Perspective
7. Thailand To Test Efficacy Of Stem Cell Technology
8. Efficacy Of Sports-Formulated Jelly Beans In Warding Off Fatigue To Be Studied
9. Indian And Chinese Doctors Join Together To Prove The Efficacy Of Herbal Drugs
10. New Study Shows Efficacy of AROMASIN on Early Breast Cancer
11. KADIAN Efficacy Not Affected by Alcohol Consumption
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/20/2017)... (PRWEB) , ... July 19, 2017 , ... ... a $1.5 million Health Resources and Services Administration (HRSA) grant to train predoctoral ... special health care needs in rural and underserved areas. , The Predoctoral Pediatric ...
(Date:7/20/2017)... ... 19, 2017 , ... A July 7th article ... varicose veins in some patients, according to medical experts. Washington State medical clinic ... excessive sitting or standing, or regularly nicking yourself while shaving your legs, and ...
(Date:7/18/2017)... ... 18, 2017 , ... CannaKids, a California Cooperative Cooperation that specializes in the ... the WORLDZ Summit, taking place in Hollywood from July 31-August 1, the Company’s ... cannabis for both pediatric and adult patients, and how the path has led her ...
(Date:7/18/2017)... ... July 18, 2017 , ... The results of an international clinical trial, led in part by ... severe type of muscular dystrophy holds promise for a subgroup of patients. , In a ... and colleagues at 53 study sites in 18 countries describe the clinical benefit of using ...
(Date:7/18/2017)... ... July 18, 2017 , ... An inventor from Seattle, Wash., has developed ... to clean, scrub and moisturize the back and other hard-to-reach areas of the body. ... movement in my upper body, particularly my shoulders. I found it difficult to reach ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... Corp., also known as ,The Epigenetics Company, announced today the release of ... using the myDNAge ™ test. Based on Horvath,s Clock, so named ... biostatistics at the David Geffen School of Medicine at UCLA ... ™ technology is used to analyze DNA methylation patterns of over ... Epigenetic ...
(Date:7/11/2017)... , July 11, 2017 Oramed Pharmaceuticals ... a clinical-stage pharmaceutical company focused on the development of ... Food and Drug Administration (FDA) has agreed to schedule ... completed Phase IIb trial of its oral insulin capsule ... Phase IIb trial met primary and secondary endpoints by ...
(Date:7/10/2017)... TRIANGLE PARK, N.C. , July 10, 2017 /PRNewswire/ ... a $5m Convertible Note to support the development of ... by Tencent Holdings Limited, a leading Chinese Internet services ... This funding will advance multiple infectious disease product programs ... Founded by Dr. ...
Breaking Medicine Technology: